{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:10:32Z","timestamp":1778044232958,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 EY016665"],"award-info":[{"award-number":["P30 EY016665"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008028","name":"School of Medicine and Public Health, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.expneurol.2025.115227","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T07:18:17Z","timestamp":1742541497000},"page":"115227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Promotion of remyelination by a thyromimetic drug leading to functional recovery"],"prefix":"10.1016","volume":"389","author":[{"given":"Ian D.","family":"Duncan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Vivian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin K.","family":"August","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Keuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Komro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Radecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Kiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelyn","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Starr","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Rylander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N.","family":"Ver Hoeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1750-3639.2006.00043.x","article-title":"Extensive cortical remyelination in patients with chronic multiple sclerosis","volume":"17","author":"Albert","year":"2007","journal-title":"Brain Pathol."},{"issue":"Pt A","key":"10.1016\/j.expneurol.2025.115227_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.expneurol.2016.06.033","article-title":"A mouse model for testing remyelinating therapies","volume":"283","author":"Bai","year":"2016","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115227_bb0015","first-page":"247","article-title":"3,5,3\u2032-Triiodo-L-Thyronine regulates actin cytoskeleton dynamic in the differentiated PC-12 cells during hypoxia through an alphavbeta3 integrin","volume":"25","author":"Barbakadze","year":"2023","journal-title":"Cell J."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115227_bb0020","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1242\/dev.120.5.1097","article-title":"A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development","volume":"120","author":"Barres","year":"1994","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.expneurol.2025.115227_bb0025","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/glia.22697","article-title":"A selective thyroid hormone beta receptor agonist enhances human and rodent oligodendrocyte differentiation","volume":"62","author":"Baxi","year":"2014","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115227_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/13524585221075990","article-title":"Pathways to cures for multiple sclerosis: a research roadmap","volume":"28","author":"Bebo","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.expneurol.2025.115227_bb0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuroimage.2017.06.076","article-title":"Evaluating g-ratio weighted changes in the corpus callosum as a function of age and sex","volume":"182","author":"Berman","year":"2018","journal-title":"Neuroimage"},{"issue":"23","key":"10.1016\/j.expneurol.2025.115227_bb0040","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1093\/emboj\/cdf662","article-title":"Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1)","volume":"21","author":"Billon","year":"2002","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.expneurol.2025.115227_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","article-title":"Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR one): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study","volume":"20","author":"Brown","year":"2021","journal-title":"Lancet Neurol."},{"issue":"Pt 3","key":"10.1016\/j.expneurol.2025.115227_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/brain\/124.3.468","article-title":"Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study","volume":"124","author":"Brusa","year":"2001","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115227_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.brainresrev.2004.12.022","article-title":"Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease","volume":"48","author":"Calza","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115227_bb0065","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1354\/vp.44-6-912","article-title":"Leukoencephalomyelopathy in specific pathogen-free cats","volume":"44","author":"Cassidy","year":"2007","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.expneurol.2025.115227_bb0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.nbd.2014.08.019","article-title":"Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats","volume":"71","author":"Castelo-Branco","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"20","key":"10.1016\/j.expneurol.2025.115227_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217635120","article-title":"MWF of the corpus callosum is a robust measure of remyelination: results from the ReBUILD trial","volume":"120","author":"Caverzasi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.expneurol.2025.115227_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1751-0813.2009.00475.x","article-title":"Ataxia and paralysis in cats in Australia associated with exposure to an imported gamma-irradiated commercial dry pet food","volume":"87","author":"Child","year":"2009","journal-title":"Aust. Vet. J."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115227_bb0085","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41467-025-56092-6","article-title":"Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function","volume":"16","author":"Della-Flora Nunes","year":"2025","journal-title":"Nat. Commun."},{"issue":"7471","key":"10.1016\/j.expneurol.2025.115227_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.expneurol.2025.115227_bb0095","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2826.2011.02181.x","article-title":"Triiodothyronine administration ameliorates the demyelination\/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism","volume":"23","author":"D\u2019Intino","year":"2011","journal-title":"J. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115227_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mcn.2012.03.007","article-title":"The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration","volume":"50","author":"Dugas","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"issue":"16","key":"10.1016\/j.expneurol.2025.115227_bb0105","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1073\/pnas.0812500106","article-title":"Extensive remyelination of the CNS leads to functional recovery","volume":"106","author":"Duncan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"45","key":"10.1016\/j.expneurol.2025.115227_bb0110","doi-asserted-by":"crossref","first-page":"E9685","DOI":"10.1073\/pnas.1714183114","article-title":"Thin myelin sheaths as the hallmark of remyelination persist over time and preserve axon function","volume":"114","author":"Duncan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.expneurol.2025.115227_bb0115","doi-asserted-by":"crossref","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","article-title":"The adult oligodendrocyte can participate in remyelination","volume":"115","author":"Duncan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.expneurol.2025.115227_bb0120","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1523\/JNEUROSCI.17-19-07267.1997","article-title":"Conduction in segmentally demyelinated mammalian central axons","volume":"17","author":"Felts","year":"1997","journal-title":"J. Neurosci."},{"issue":"46","key":"10.1016\/j.expneurol.2025.115227_bb0125","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0407262101","article-title":"Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease","volume":"101","author":"Fernandez","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.expneurol.2008.04.039","article-title":"Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination","volume":"212","author":"Franco","year":"2008","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115227_bb0135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin - from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115227_bb0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020594","article-title":"Glia disease and repair-remyelination","volume":"7","author":"Franklin","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10111","key":"10.1016\/j.expneurol.2025.115227_bb0145","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"issue":"7758","key":"10.1016\/j.expneurol.2025.115227_bb0150","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0140-6736(72)91155-5","article-title":"Delayed visual evoked response in optic neuritis","volume":"1","author":"Halliday","year":"1972","journal-title":"Lancet"},{"issue":"52","key":"10.1016\/j.expneurol.2025.115227_bb0155","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1523\/JNEUROSCI.4453-08.2008","article-title":"Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging","volume":"28","author":"Harsan","year":"2008","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115227_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126329","article-title":"Myelin repair stimulated by CNS-selective thyroid hormone action","volume":"4","author":"Hartley","year":"2019","journal-title":"JCI Insight"},{"issue":"52","key":"10.1016\/j.expneurol.2025.115227_bb0165","doi-asserted-by":"crossref","first-page":"27074","DOI":"10.1073\/pnas.1906358116","article-title":"Evoked potentials as a biomarker of remyelination","volume":"116","author":"Heidari","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115227_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid X receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2025.115227_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/120.1.27","article-title":"Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination","volume":"120","author":"Jeffery","year":"1997","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-510X(02)00428-8","article-title":"Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection","volume":"206","author":"Jones","year":"2003","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115227_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/thy.1997.7.147","article-title":"Thyroid hormone-regulated actin polymerization in brain","volume":"7","author":"Leonard","year":"1997","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.expneurol.2025.115227_bb0190","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0058-23.2023","article-title":"Excessive thyroid hormone signaling induces photoreceptor degeneration in mice","volume":"10","author":"Ma","year":"2023","journal-title":"eNeuro"},{"issue":"8","key":"10.1016\/j.expneurol.2025.115227_bb0195","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2025.115227_bb0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"Elife"},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2025.115227_bb0205","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/brain\/124.7.1403","article-title":"Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis","volume":"124","author":"Murray","year":"2001","journal-title":"Brain"},{"issue":"7555","key":"10.1016\/j.expneurol.2025.115227_bb0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.expneurol.2025.115227_bb0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","article-title":"Metformin restores CNS Remyelination capacity by rejuvenating aged stem cells","volume":"25","author":"Neumann","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115227_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","article-title":"ISCEV standard for clinical visual evoked potentials: (2016 update)","volume":"133","author":"Odom","year":"2016","journal-title":"Doc. Ophthalmol."},{"issue":"17","key":"10.1016\/j.expneurol.2025.115227_bb0225","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/S0042-6989(99)00016-4","article-title":"Properties of the flash visual evoked potential recorded in the cat primary visual cortex","volume":"39","author":"Padnick","year":"1999","journal-title":"Vis. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115227_bb0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2990.2007.00805.x","article-title":"Remyelination can be extensive in multiple sclerosis despite a long disease course","volume":"33","author":"Patani","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"Pt 12","key":"10.1016\/j.expneurol.2025.115227_bb0235","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ana.410330203","article-title":"Multiple sclerosis: remyelination of nascent lesions","volume":"33","author":"Prineas","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2025.115227_bb0245","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2022"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115227_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228109","article-title":"Feline irradiated diet-induced demyelination; a model of the neuropathology of sub-acute combined degeneration?","volume":"15","author":"Radcliff","year":"2020","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.expneurol.2025.115227_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115973119","article-title":"Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction","volume":"119","author":"Sarrazin","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/brain\/104.2.383","article-title":"The restoration of conduction by central remyelination","volume":"104","author":"Smith","year":"1981","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115227_bb0265","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.dib.2015.05.019","article-title":"Quantitative analysis of the myelin g-ratio from electron microscopy images of the macaque corpus callosum","volume":"4","author":"Stikov","year":"2015","journal-title":"Data Brief"},{"issue":"5","key":"10.1016\/j.expneurol.2025.115227_bb0270","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/jpn.13139","article-title":"Leukoencephalomyelopathy in cats linked to abnormal fatty acid composition of the white matter of the spinal cord and of irradiated dry cat food","volume":"103","author":"van den Ingh","year":"2019","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115227_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.devcel.2015.06.011","article-title":"CNS myelin wrapping is driven by actin disassembly","volume":"34","author":"Zuchero","year":"2015","journal-title":"Dev. Cell"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:11:22Z","timestamp":1778040682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"alternative-id":["S0014488625000913"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115227","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promotion of remyelination by a thyromimetic drug leading to functional recovery","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115227"}}